Cargando…
Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and so...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624212/ https://www.ncbi.nlm.nih.gov/pubmed/34834589 http://dx.doi.org/10.3390/jpm11111236 |
_version_ | 1784606118601818112 |
---|---|
author | Fino, Edita Russo, Paolo Maria Tengattini, Vera Bardazzi, Federico Patrizi, Annalisa Martoni, Monica |
author_facet | Fino, Edita Russo, Paolo Maria Tengattini, Vera Bardazzi, Federico Patrizi, Annalisa Martoni, Monica |
author_sort | Fino, Edita |
collection | PubMed |
description | A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and social anxiety in modulating quality of life in psoriatic patients. A total of 130 patients affected by psoriasis were consecutively enrolled in the study as they approached the Dermatology Unit of Sant’Orsola-Malpighi Hospital of Bologna. Clinical information gathered included illness severity, assessed with the Psoriasis Area and Severity Index (PASI) and the Body Surface Area (BSA); illness onset; familiarity; and prescribed treatment. The patient-reported outcome measures were the Dermatology Life Quality Index (DLQI), measuring the patient’s quality of life; the Psoriasis Skin Appearance Bothersomeness scale (PSAB), measuring patient’s perception of illness severity; the Difficulties in Emotion Regulation Scale (DERS), assessing emotion dysregulation traits; and the Social Interaction Anxiety Scale (SIAS), measuring anxiety about social interactions. Patients with moderate-to-severe psoriasis reported significantly lower quality of life compared to mildly affected patients. In addition, of the patients affected by mild psoriasis, those characterized by emotion dysregulation and social anxiety traits showed significantly lower levels of quality of life. Our findings suggest that individual differences in emotion dysregulation and social anxiety contribute to health-related quality of life in addition to illness severity. Therapeutic approaches that combine dermatological care with psychological support, especially focused on emotional regulation skills, may be useful to improve clinical outcomes in patients with psoriasis. |
format | Online Article Text |
id | pubmed-8624212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86242122021-11-27 Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis Fino, Edita Russo, Paolo Maria Tengattini, Vera Bardazzi, Federico Patrizi, Annalisa Martoni, Monica J Pers Med Article A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and social anxiety in modulating quality of life in psoriatic patients. A total of 130 patients affected by psoriasis were consecutively enrolled in the study as they approached the Dermatology Unit of Sant’Orsola-Malpighi Hospital of Bologna. Clinical information gathered included illness severity, assessed with the Psoriasis Area and Severity Index (PASI) and the Body Surface Area (BSA); illness onset; familiarity; and prescribed treatment. The patient-reported outcome measures were the Dermatology Life Quality Index (DLQI), measuring the patient’s quality of life; the Psoriasis Skin Appearance Bothersomeness scale (PSAB), measuring patient’s perception of illness severity; the Difficulties in Emotion Regulation Scale (DERS), assessing emotion dysregulation traits; and the Social Interaction Anxiety Scale (SIAS), measuring anxiety about social interactions. Patients with moderate-to-severe psoriasis reported significantly lower quality of life compared to mildly affected patients. In addition, of the patients affected by mild psoriasis, those characterized by emotion dysregulation and social anxiety traits showed significantly lower levels of quality of life. Our findings suggest that individual differences in emotion dysregulation and social anxiety contribute to health-related quality of life in addition to illness severity. Therapeutic approaches that combine dermatological care with psychological support, especially focused on emotional regulation skills, may be useful to improve clinical outcomes in patients with psoriasis. MDPI 2021-11-21 /pmc/articles/PMC8624212/ /pubmed/34834589 http://dx.doi.org/10.3390/jpm11111236 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fino, Edita Russo, Paolo Maria Tengattini, Vera Bardazzi, Federico Patrizi, Annalisa Martoni, Monica Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis |
title | Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis |
title_full | Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis |
title_fullStr | Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis |
title_full_unstemmed | Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis |
title_short | Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis |
title_sort | individual differences in emotion dysregulation and social anxiety discriminate between high vs. low quality of life in patients with mild psoriasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624212/ https://www.ncbi.nlm.nih.gov/pubmed/34834589 http://dx.doi.org/10.3390/jpm11111236 |
work_keys_str_mv | AT finoedita individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis AT russopaolomaria individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis AT tengattinivera individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis AT bardazzifederico individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis AT patriziannalisa individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis AT martonimonica individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis |